TROW
56
5
WBA
48
4
CAH
48
-5
PNC
64
4
BF.B
33
2
A
43
2
CF
57
-2
CSX
60
3
HSIC
56
5
CINF
53
2
KMI
67
-2
SE
61
-4
RSG
71
3
INTU
56
-4
NRG
49
-3
DOW
44
10
WM
79
3
PFG
45
3
WAT
55
2
BBY
46
10
TROW
56
5
WBA
48
4
CAH
48
-5
PNC
64
4
BF.B
33
2
A
43
2
CF
57
-2
CSX
60
3
HSIC
56
5
CINF
53
2
KMI
67
-2
SE
61
-4
RSG
71
3
INTU
56
-4
NRG
49
-3
DOW
44
10
WM
79
3
PFG
45
3
WAT
55
2
BBY
46
10
Financhill
Back

Bone Biologics Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7

BBLG
Bone Biologics

Last Price:
1.28
Seasonality Move:
-17.7%

7 Day Trial

ALL ACCESS PASS

$ 7

Say this - unlock as much as $1,250 every Friday

Click here for full details.

Bone Biologics Price Quote

$1.28
+0.03 (+4.07%)
(Updated: November 23, 2024 at 5:26 AM ET)

Bone Biologics Key Stats

Sell
7
Bone Biologics (BBLG) is a Sell
Day range:
$1.22 - $1.29
52-week range:
$0.80 - $10.56
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.81%
Volume:
32.8K
Avg. volume:
274.8K
1-year change:
-67.85%
Market cap:
$3.1M
Revenue:
$0
EPS:
$-7.25

How Much Does Bone Biologics Make?

Data Unavailable

Is Bone Biologics Growing As A Company?

Data Unavailable

Bone Biologics Stock Price Performance

  • Did Bone Biologics Stock Go Up Last Month?
    Bone Biologics share price went down by -30.94% last month
  • Did BBLG's Share Price Rise Over The Last Year?
    BBLG share price fell by -67.85% over the past 1 year

What Is Bone Biologics 52-Week High & Low?

Bone Biologics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bone Biologics?

  • How Much Debt Does Bone Biologics Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bone Biologics Have?
    Cash and short term investments quarterly total is $3.6M
  • What Is Bone Biologics’s Book Value Per Share?
    Book value per share is 1.81

Is Bone Biologics Cash Flow Positive?

  • What Is BBLG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.8M
  • What Is Bone Biologics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $3.9M
  • What Is Bone Biologics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bone Biologics Return On Invested Capital

Data Unavailable

Bone Biologics Earnings Date & Stock Price

Bone Biologics Competitors

  • Who Are Bone Biologics's Competitors?
    Below is a list of companies who compete with Bone Biologics or are related in some way:
    • Dermata Therapeutics Inc (DRMA)
    • iBio Inc (IBIO)
    • Johnson & Johnson (JNJ)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Bone Biologics Dividend Yield

Bone Biologics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -295%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 16.75
Upside from Last Price: 1240%

Major Shareholders

  • How many BBLG shares are owned by institutional investors?
    76.4K BBLG shares are owned by institutional investors
  • How many BBLG shares are owned by insiders?
    0 BBLG shares are owned by insiders